Analysis of mechanism on enhancement of fibrinolysis as biological defense
Analysis of mechanism on enhancement of fibrinolysis as biological defense
批准号:
13470519
负责人:
WADA Hideo
金额:
$6.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The prevention of the thrombosis in the old people becomes an important problem. The aging seemed to be large risk of the thrombosis, and we examined the relation between hemostasis abnormality and aging. In the examination of the maintenance dialysis patient, the death and crisis frequency which accompanied thrombosis increased with the aging. With the aging, there were calcification of the aorta and progress of the arteriosclerosis. In more than 70 years old of healthy volunteer, antithrombin and protein C reduced and thrombin- antithrombin complex and soluble fibrin levels were increased. While, in those, fibrinogen and fibrin degradation products and plasmin- plasmin inhibitor complex levels were increased, suggesting that hyperfibrinolysis exist in old peoples. However old health peoples had no secondary fibrinolysis due to thrombosis. These results indicated that physiological enhancement in fibrinolytic system was caused by aging. There are plasminogen activator (t-PA), plasmino … More gen activator inhibitor (PAI)-I, II, III and thrombin activatable fibrinolysis inhibitor (TAFI) in regulatory system of fibrinolysis. We established the usefulness of measurement in total PAI-I, tPA-PAI-I complex, TAFI and tPA by ELISA for the diagnosis of disseminated intravascular coagulation (DIG), deep vein thrombosis (DVT), and multiple organ failure (MOF) and acute myocardial infarction. As plasma levels of total PAI-I and TAFI were increased in old peoples, these factors may play an important role of the onset in thrombosis. It was suggested that elevated plasma levels of PAI-I was related to the polymorphism of promoter in PAI-I gene (4G/5G). After informed consent, the polymorphism of promoter in PAI-I gene (4G/5G) was examined in old peoples.There was no significant difference of distribution in the polymorphism between young peoples and old peoples. Our results showed no relationship between polymorphism of PAI-I gene promoter and thrombosis in old peoples. Finally, old peoples had high risk for thrombosis and significant atherosclerosis, however they were in hyperfibrinolytic state. Less
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
0hta S, Wada H, et al: "Evaluation of tissue factor antigen level in human seminal plasma"Urol Res. 30. 317-320 (2002)
0hta S,Wada H,等人:“人精浆中组织因子抗原水平的评估”Urol Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamaki S, Wada H, et al: "Hemostatic abnormalities following bone marrow transplantation"Clin Appl Thromb Hemost. 8. 125-132 (2002)
Tamaki S、Wada H 等人:“骨髓移植后的止血异常”Clin Appl Thromb Hemost。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakasaki T, Wada H, et al.: "Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer"Am J Hematol. (in press)(印刷中). (2002)
Nakasaki T、Wada H 等人:“组织因子和血管内皮生长因子的表达与结直肠癌中的血管生成有关”Am J Hematol(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wada H, Mori Y, et al.: "High plasma levels of fibrinogen are associated with poor outcome"Am J Hematol. 72・1. 1-7 (2003)
Wada H、Mori Y 等人:“高血浆纤维蛋白原水平与不良结果相关”Am J Hematol. 72·1 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, et al: "Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary,artery disease"Am Heart J. 142. (2001)
Kitai T、Nishikawa M、Tanikawa T、Okinaka T、Wada H 等人:“在患有冠状动脉疾病的患者中,通过使用噻氯匹定和阿司匹林联合治疗对增强的血小板聚集进行抑制”Am Heart J. 142(2001 年)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
Monitoring for anticoagulant therapy and mechanism for anticoagulant
-
批准号:24590692
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:WADA Hideo
-
依托单位:
Study on early diagnosis of hypercoagulable state and mechanism for the onset in thrombosis
-
批准号:21590623
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2009
-
负责人:WADA Hideo
-
依托单位:
Identification of antigen for cause of ITP by the new molecular biological method (SEREX)
-
批准号:10670943
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.64万
-
财政年份:1998
-
负责人:WADA Hideo
-
依托单位:
RELATIONSHIP BETWEEN VASCULAR ENDOTHELIAL CELL INJURIES AND RED CELL FRAGMENTATION SYNDROME
-
批准号:06671086
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:WADA Hideo
-
依托单位:
海外基金